1. No category

07/05/2015
Bedrocan May Newsletter
A bridge between patients' needs for cannabis and the quality
standards of modern medicine.
Thank you for putting your trust in Bedrocan Canada Inc. PATIENT ADVISORY BOARD (PAB) MEETING A SUCCESS
Inaugural Meeting Held in Toronto on April 8th
Ten Bedrocan Patients from across the country met in Toronto for the inaugural meeting of the
Patient Advisory Board. The members of the board range in age from 22 to 67, have a wide
variety of medical conditions, perspectives, and experiences relating to medical cannabis.
In an intensive 8 hour meeting with members of the Bedrocan executive team, the Patient
Advisory Board:
offered meaningful suggestions to improve customer service
defined key tips to support patients new to using cannabis as a medicine
identified and initiated an advocacy project
enhanced their knowledge about medical cannabis
Moving forward we will identify ways to enhance and improve the Patient Advisory Board’s
importance and relevance so that Bedrocan’ s evolution is more informed by patient needs.
Watch for more information about the Patient Advisory Board in upcoming newsletters. BEDROCAN SPONSORS EDUCATIONAL SYMPOSIUM AT 2015
PRIMARY CARE TODAY CONFERENCE MAY 7th
Dr. Marcia Gillman to present on the topic of:
"Medical Cannabis: Clearing Away the Smoke"
http://us3.campaign­archive1.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=bee4384770&e=eff51974ff
1/3
07/05/2015
Bedrocan May Newsletter
The Bedrocan sponsored symposium; “Medical Cannabis:
Clearing Away the Smoke” will address many of the current
issues facing physicians who may be apprehensive about
authorizing access to medical cannabis. With the establishment of the Marijuana for Medical
Purposes Regulations (MMPR) in Canada, in 2014, the responsibility of authorizing the use of
medical cannabis for patients falls entirely on physicians. Doctors are under no obligation, legal
or otherwise, to authorize medical cannabis for patients. Many are apprehensive as they feel
the current evidence base is insufficient, nor is cannabis approved as a drug. Other physicians
still have some issues with stigma, and are reluctant to authorize medical cannabis. Still others
may be open to its use as a medicine, but are insufficiently equipped to define its role in clinical
practice. This situation puts many doctors in a difficult position. Many physicians require
ongoing information and education on the utilization of medical cannabis for medical purposes;
Dr. Gillman will address these issues and more in her presentation. WEBINAR ON SAFER USE & BETTER HEALTH Canadian AIDS Society Developing Education Tools to Better Help Patients
Bedrocan Director of Patient and Community
Services, Hilary Black, is developing a webinar on the
“Safer Use and Better Health” with medical cannabis
in conjunction with The Canadian Aids Society. The
webinar will be live and open to you attending, on
June 10th. Watch next months newsletter for details.
WE WANT TO HEAR FROM YOU
Do you have an idea for a topic or article that you want to see in the
Newsletter?
http://us3.campaign­archive1.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=bee4384770&e=eff51974ff
2/3
07/05/2015
Bedrocan May Newsletter
We would love to hear your suggestions and ideas for the Newsletter. Please email any
suggestions to: [email protected] with the subject: "Newsletter Ideas". How to Reach Us
We love to hear your feedback. You can always send us an email, call us, or visit our Twitter
and Facebook pages to ask questions or send us your comments.
We post our newsletters on our website here: www.bedrocan.ca/newsletter . Thank you for taking the time to read our newsletter. Should you have any questions about
the content of this message, the MMPR program, the medicinal cannabis industry or Bedrocan
Canada, please get in touch with us; we’d like to hear from you!
Bedrocan Canada customer service professionals await your registration, orders and
questions:
In the GTA: 416­943­5800
Outside the GTA (Canada only) Toll­Free: 1­855­420­7887
Email us at: [email protected]
Copyright © 2015 Bedrocan Canada Inc., All rights reserved.
forward to a friend unsubscribe from this list update subscription preferences http://us3.campaign­archive1.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=bee4384770&e=eff51974ff
3/3